What does CUSIP 09058V103 represent in this 13F holders report?

CUSIP 09058V103 is the security identifier for BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in Q4 2022?

225 institutional investors reported BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock for Q4 2022. Use the holders table for investor-level position and value details.

BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

CUSIP: 09058V103

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock
Shares outstanding: 210,587,372
Total 13F shares: 157,670,070
Share change: +8,231,623
Total reported value: $1,809,819,957
Put/Call ratio: 38%
Price per share: $11.48
Number of holders: 225
Value change: +$89,114,288
Number of buys: 123
Number of sells: 85

Quarterly Holders Quick Answers

What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 09058V103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	6.6%	13,838,612	$174,366,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	6.5%	13,774,995	$173,565,000	—	30 Sep 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	6%	12,710,818	$160,156,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	4.5%	9,404,247	$118,494,000	—	30 Sep 2022	13F
Avoro Capital Advisors LLC	13F	Company	4.3%	9,050,000	$114,030,000	—	30 Sep 2022	13F
FMR LLC	13F	Company	2.7%	5,707,067	$71,910,000	—	30 Sep 2022	13F
Fisher Asset Management, LLC	13F	Company	2.5%	5,163,845	$65,064,000	—	30 Sep 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	2.3%	4,813,772	$60,653,000	—	30 Sep 2022	13F
RP Management, LLC	13F	Company	1.8%	3,846,154	$48,462,000	—	30 Sep 2022	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.7%	3,520,231	$44,355,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.6%	3,365,844	$42,409,000	—	30 Sep 2022	13F
Artisan Partners Limited Partnership	13F	Company	1.3%	2,649,616	$33,385,000	—	30 Sep 2022	13F
Assenagon Asset Management S.A.	13F	Company	1.2%	2,616,157	$32,964,000	—	30 Sep 2022	13F
Fairmount Funds Management LLC	13F	Company	1.2%	2,543,107	$32,043,000	—	30 Sep 2022	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	1.1%	2,280,953	$28,740,000	—	30 Sep 2022	13F
PFM Health Sciences, LP	13F	Company	1%	2,162,411	$27,246,000	—	30 Sep 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.96%	2,015,812	$25,399,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.9%	1,902,821	$23,975,000	—	30 Sep 2022	13F
STIFEL FINANCIAL CORP	13F	Company	0.88%	1,846,174	$23,261,000	—	30 Sep 2022	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.86%	1,805,072	$22,743,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.85%	1,796,791	$22,639,000	—	30 Sep 2022	13F
Rock Springs Capital Management LP	13F	Company	0.81%	1,712,507	$21,578,000	—	30 Sep 2022	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.8%	1,681,189	$21,182,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.7%	1,469,155	$18,511,000	—	30 Sep 2022	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	0.7%	1,465,285	$18,463,000	—	30 Sep 2022	13F
GW&K Investment Management, LLC	13F	Company	0.67%	1,417,140	$17,856,000	—	30 Sep 2022	13F
Sarissa Capital Management LP	13F	Company	0.66%	1,390,790	$17,524,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.66%	1,386,148	$17,466,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.63%	1,326,442	$16,713,000	—	30 Sep 2022	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.58%	1,223,721	$15,419,000	—	30 Sep 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.57%	1,200,000	$15,120,000	—	30 Sep 2022	13F
NORGES BANK	13F	Company	0.51%	1,073,116	$13,521,262	—	30 Sep 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.49%	1,031,159	$12,993,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.46%	971,315	$12,239,000	—	30 Sep 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.45%	947,429	$11,938,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	0.43%	909,269	$11,457,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.41%	854,854	$10,770,000	—	30 Sep 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.37%	774,203	$9,755,000	—	30 Sep 2022	13F
ExodusPoint Capital Management, LP	13F	Company	0.34%	709,285	$8,937,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	0.32%	671,412	$8,460,000	—	30 Sep 2022	13F
ORACLE INVESTMENT MANAGEMENT INC	13F	Company	0.3%	635,194	$8,003,000	—	30 Sep 2022	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.3%	628,028	$7,913,153	—	30 Sep 2022	13F
MPM BioImpact LLC	13F	Company	0.29%	605,663	$7,631,000	—	30 Sep 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0.27%	573,577	$7,227,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.27%	565,380	$7,124,000	—	30 Sep 2022	13F
Ghost Tree Capital, LLC	13F	Company	0.25%	525,000	$6,615,000	—	30 Sep 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.25%	518,702	$6,535,000	—	30 Sep 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.24%	515,228	$6,492,000	—	30 Sep 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.24%	502,581	$6,333,000	—	30 Sep 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.24%	495,539	$6,244,000	—	30 Sep 2022	13F

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q4 2022

As of 31 Dec 2022, BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by 225 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 157,670,070 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, STATE STREET CORP, Avoro Capital Advisors LLC, FMR LLC, PICTET ASSET MANAGEMENT SA, Fisher Asset Management, LLC, RP Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 225 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

218

Q4 2022 holders

225

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.